483
CSL Behring GmbHFDA 483 - CSL Behring GmbH - May 17, 2018
Discuss this record with AI
Record Details
This 483 record concerns CSL Behring GmbH, with an inspection on May 17, 2018, issued by the Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality), covering biologics.
Open in Dashboard
ID · ff548397-dc14-4b14-8664-389d7c724d1c